C. ,Bárbara G.H.,Citores and J. ArancetaBartrina M.G. .2022 .Prevalence of obesity and associated cardiovascular risk factors in the spanish population: The enpe study. Rev. Española Cardiol, 75 : 232-241.
El-Bcheraoui C.,Afshin A.,Charara R.,Khalil I.,Moradi-Lakeh M. .2018 .Burden of obesity in the eastern mediterranean region: findings from the global burden of disease 2015 study. Int. J Public Health.,, 63 : 165-176.
H. ,Ansari-Moghaddam A.,Kargar S.,Jabbari N. .2022 .Prevalence of obesity and overweight among adults in the middle east countries from 2000 to 2020: A systematic review and metaanalysis. J. Obesity, 10 : .
Lopez-Jimenez .,F. .,Almahmeed W.,Bays H.,Cuevas A.,Angelantonio E.D. .2022 .Obesity and cardiovascular disease: Mechanistic insights and management strategies. a joint position paper by the world heart federation and world obesity federation. Eur. J. Preventive Cardiol, 29 : 2218-2237.
J. Wu P.,Jedrychowski M.P.,Korde A.,Ye L. .2012 .A pgc1-"-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481 : 463-468.
Panati .,K. .,Suneetha Y.,Narala V.R. .2016 .Irisin/FNDC5-An updated review. Eur. Rev. Med, 20 : 689-697.
Zhang .,Hu C.,H.M. Wu Z.G.,Ma Q.Z.,Tang Q.Z. .2020 .Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target. Acta Pharmacol. Sinica, 42 : 1390-1400.
Xiong X.Q.,Ren X.S.,Zhao M.X.,Shi C.X. .2016 .FNDC5 alleviates hepatosteatosis by restoring AMPK/mTOR-mediated autophagy, fatty acid oxidation and lipogenesis in mice. Diabetes, 65 : 3262-3275.
Zhang .,Hu C.,Kong C.Y.,Song and H.M. Wu P. .2019 .Cell Death Differ. , 27 : 540-555.
C. ,Zhang X.,Teng T.,Yuan Y. .2022 .Fibronectin type III domain containing 5 improves aging related cardiac dysfunction in mice. Aging Cell, 21 : .
J.D.S. ,Camacho F.A.,Cavararo C.D.S.,Baião P.F.,Medeiros R.F.,Barroso S.G.,A.C.D. Matos S.G. .2023 .Irisin and cardiometabolic disorders in obesity: A systematic review. Int. J. Inflam., 10 : .
W. ,Shaker Y.,Hamimy W.I.,Afify M. .2018 .Assessment of serum vitamin D and irisin levels in obese patients. Clin. Lab., 64 : 180416.
Marandi S.M.,Ghaedi K.,Safaeinejad Z.,Esfarjani F.,Nasr-Esfahani M.H.,Nutr M.H. .2018 .A comparative study on the effects of high-fat diet and endurance training on the PGC-1"-FNDC5/Irisin pathway in obese and nonobese male C57BL/6 mice. , 43 : 651-662.
F. ,Benomar K.,Espiard S.,Vahe and K.L. Mapihan C. .2019 .Irisin levels in LMNA-associated partial lipodystrophies. Diabetes Metab, 45 : 67-75.
B.M. ,Pena-Bello L.,Juiz-Valiña P.,VidalBretal B.,Cordido F.,Sangiao-Alvarellos S. .2016 .FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle. Sci. Rep, 6 : .
D. ,Roca-Rivada A.,I. Baamonde A.,Baltar J.,A.I. Castro J. .2017 .Lack of adipocyte-Fndc5/Irisin expression and secretion reduces thermogenesis and enhances adipogenesis. Sci. Rep, 7 : .
S. ,Li F.,Li H.,Huang Y.,Liu Y.,Chen Y. .2016 .Effects and Molecular Mechanism of GST-Irisin on Lipolysis and Autocrine Function in 3T3-L1 Adipocytes. Plos One, 0147480 : .
J.M. ,Ortega F.,Serrano M.,Guerra E.,Pardo G. .2013 .Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J. Clin. Endocrinol. Metab., 98 : E769-E778.
B. ,Shi X.,Zhang H.,Pan L.,Ma Z. .2014 .Association of serum irisin with metabolic syndrome in obese Chinese adults. Plos One, 0094235 : .
W.K.C. ,Yu A.P.,Lai and P.M. Siu C.W.K. .2018 .Association of markers of proinflammatory phenotype and beige adipogenesis with metabolic syndrome in Chinese centrally obese adults. J. Diabetes Res., 10 : .
Panagiotou G.,Mougios V.,Brinkoetter M.,Vamvini M.T.,Schneider B.E.,Mantzoros C.S. .2012 .circulating concentrations in response to weight loss and exercise. Metabolism, 61 : 1725-1738.
J. ,Rosa A.,Azcona-Granada N.,Peña E.,Ricart-Jané D. .2023 .Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity. Int. J. Mol. Sci., 24 : .
M.H. ,Alotaibi F.,Dsouza C. .2022 .Changes in the expression of meteorin-like (METRNL), irisin (FNDC5) and uncoupling proteins (UCPs) after bariatric surgery. Obesity, 30 : 1629-1638.
G. ,Mu L.,Na B.,Mukamal K.J.,Mantzoros C.S. .2014 .Circulating irisin, omentin-1 and lipoprotein subparticles in adults at higher cardiovascular risk. Metabolism, 63 : 1265-1271.
Ancira M. .2015 .Irisin levels before and after physical activity among school-age children with different BMI: a direct relation with leptin. Obesity, 23 : 729-732.
Kim H.J.,Kang J.H.,Park S.I.,Park K.H.,Lee H.J. .2017 .Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Metabolism, 73 : 100-108.
Ebrahimzadeh F.,Abbasnezhad A.,Khosroshahi M.Z.,Choghakhori R.,Asbaghi O. .2019 .Association between circulating irisin and c-reactive protein levels: A systematic review and metaanalysis. Endocrinol. Metab., 3 : .
A. ,Rouskas K.,Pattou F.,Staels B. .2015 .Bariatric surgery, lipoprotein metabolism and cardiovascular risk. Curr. Opin. Lipidology, 26 : 317-324.
J.F. ,Larson M.G.,Vasan R.S.,Wilson P.W.F.,I. Lipinska P.W.F. .2003 .Obesity and systemic oxidative stress. Arteriosclerosis Thrombosis Vasc. Biol, 23 : 434-439.
Grubman S.,Allen S.,Ye Z.,Park D.Y. .2024 .Clinical interpretation of serum troponin in the era of high-sensitivity testing. Diagnostics, 14 : .
C.E. ,Matsushita K.,Shay C.M.,Folsom A.R.,Ballantyne C.M.,Brancati F.L. .2016 .High-sensitivity troponin T as an independent predictor of heart failure in chronic kidney disease: The ARIC study. Circulation, 133 : 145-151.
A. ,Patel K.V.,Gao A.,Ayers C.,Ballantyne C.M.,Drazner M.H. .2019 .Incorporation of high-sensitivity troponin T into cardiovascular risk assessment algorithms: Insights from the Dallas Heart Study. Circulation, 140 : 541-551.
Y. ,Li R.,Meng Y.,Li S.,Donelan W. .2014 .Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes, 63 : 514-525.
J.D. Linderman P.,Smith S.,Brychta R.J.,Wang J. .2014 .Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab, 19 : 302-309.
Xie C.,Wang H.,Foss R.M.,Clare M. .2016 .Irisin exerts dual effects on browning and adipogenesis of human white adipocytes. Am. J. Physiol. Endocrinol. Metab., 311 : E530-E541.
H. ,Shen J.,Wu T.,Kuang J.,Liu Q. .2019 .Irisin is controlled by farnesoid X receptor and regulates cholesterol homeostasis. Front. Pharmacol., 00548 : .
L. ,Uzel K.E.,Tanriverdi O.,Turkmen S. .2020 .Serum irisin: Pathogenesis and clinical research in cardiovascular diseases. Cardiovasc. Innovations Appl., 4 : 195-200.
J. ,Cuello E.,Ricart-Jané D.,Miñarro A.,Baena-Fustegueras J.A.,Peinado-Onsurbe J.,Pardina E. .2020 .Effect of bariatric surgery on inflammation and endothelial dysfunction as processes underlying subclinical atherosclerosis in morbid obesity. Surg, 16 : 1961-1970.
M.L. .2006 .Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr. Med. Res. Opin., 22 : 2181-2190.
K. ,Chin-Dusting J. .2007 .Therapeutic targeting of pselectin in atherosclerosis. Inflamm. Allergy Drug Targets, 6 : 69-74.
Liu M.,Mei W.,Xiang L.,Dong J. .2015 .Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Atherosclerosis, 243 : 438-448.
Mu Q.,Zhou Z.,Song H.,Zhang Y. .2016 .Protective effect of irisin on atherosclerosis via suppressing oxidized low density lipoprotein induced vascular inflammation and endothelial dysfunction. Plos One, 01 : .
El-Sherbeiny and M.Z. Boraie S.M.S. .2018 .Correlation between the blood level of irisin and the severity of acute myocardial infarction in exercise-trained rats. J. Basic Clin. Physiol. Pharmacol., 30 : 59-71.
D. ,Melekoglu A.,Calik M.,Kosem A. .2023 .Association between serum irisin levels and ST-segment elevation myocardial infarction. Int. J. Gen. Med, 16 : 1355-1362.
R. ,Zhang Q.,Peng N.,Xu S.,Zhang M. .2021 .Inverse correlation between serum irisin and cardiovascular risk factors among Chinese overweight/obese population. Bmc Cardiovasc. Disord., 21 : .